Approval · Notice of Compliance 31166 · 2023
PMS-VANCOMYCIN: Notice of Compliance 31166
Issued July 10, 2023
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 31166
- Date
- July 10, 2023
- Company
- Pharmascience Inc.Montreal, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Abbreviated New Drug Submission (ANDS)
- Submission class
- Admin
- Reason
- Administrative: Change in Product Ownership
- Canadian reference product
- VANCOCIN (Merus Labs Inc.)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| PMS-VANCOMYCIN | 02406497 | Dormant |
| PMS-VANCOMYCIN | 02406500 | Dormant |
Medicinal ingredients
- VANCOMYCIN HYDROCHLORIDE 125 MG per CAP
- VANCOMYCIN HYDROCHLORIDE 250 MG per CAP